Latest News

Genprex, Inc. Announces Closing of $17,500,000 Common Stock Offering At-The-Market and Without Warrants



AUSTIN, Texas & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Genprex, Inc. Announces Closing of $17,500,000 Common Stock Offering At-The-Market and Without Warrants.

Source link

Related posts

Irish Healthcare Awards 2017 winner now working with gardaĆ­

Newsemia

Vuzix Smart Glasses for Telemedicine: Interview with Paul Travers, Vuzix CEO

Newsemia

Flu Season Tips For Protection Against Infection

Newsemia

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy

COVID-19

COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World